CANbridge Pharmaceuticals Inc. (HKG:1228)

CANbridge Pharmaceuticals Revenue

CANbridge Pharmaceuticals had revenue of 22.25M CNY in the half year ending June 30, 2025, a decrease of -48.32%. This brings the company's revenue in the last twelve months to 62.56M, down -40.20% year-over-year. In the year 2024, CANbridge Pharmaceuticals had annual revenue of 85.10M, down -17.27%.

• Revenue (ttm): 62.56M CNY
• Revenue Growth: -40.20%
• P/S Ratio: 20.81
• Revenue / Employee: 1.39M CNY
• Employees: 45
• Market Cap: 1.43B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	85.10M	-17.77M	-17.27%
Dec 31, 2023	102.87M	23.90M	30.26%
Dec 31, 2022	78.97M	47.81M	153.43%
Dec 31, 2021	31.16M	19.13M	158.98%
Dec 31, 2020	12.03M	10.56M	719.06%